All Stories

  1. Does Concomitant Methotrexate During Rituximab Treatment in Granulomatosis With Polyangiitis (Wegener's) Increase the Risk of Severe Infection? Comment on the Article by Azar et al

    Article • Arthritis & Rheumatology, June 2015, Wiley

    Dr emilio besada

  2. Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis

    Article • PeerJ, June 2015, PeerJ

    Dr emilio besada

  3. Comment on: Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice

    Article • Rheumatology, January 2015, Oxford University Press (OUP)

    Dr emilio besada

  4. In Rheumatoid Arthritis, IV and SC tocilizumab is equally effective.

    Article • Patient Preference and Adherence, August 2014, Dove Medical Press

    Dr emilio besada

  5. FRI0467 Low CD4/Cd8 Ratio is Associated with Lower Immunoglobulin Levels in Granulomatosis with Polyangiitis Patients Receiving Rituximab

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Dr emilio besada

  6. FRI0468 Chronic Nasal Carriage of Staphylococcus Aureus Does not Increase the Risk of Relapse and Severe Infections in Granulomatosis with Polyangiitis Patients When Receiving Rituximab Maintenance Treatment

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Dr emilio besada

  7. Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis

    Article • Rheumatology, May 2014, Oxford University Press (OUP)

    Dr emilio besada

  8. Is There an Interactive Effect of Immunoglobulin Levels and CD4+ Cell Counts During Rituximab Treatment? Comment on the Article by Mélet et al

    Article • Arthritis & Rheumatology, March 2014, Wiley

    Dr emilio besada

  9. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre

    Article • Rheumatology, August 2013, Oxford University Press (OUP)

    Dr emilio besada

  10. Routine Pneumocystis Pneumonia Prophylaxis in Patients Treated With Rituximab?

    Article • CHEST Journal, July 2013, Elsevier

    Dr emilio besada

  11. Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?

    Article • Clinical Rheumatology, June 2013, Springer Science + Business Media

    Dr emilio besada

  12. Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review

    Article • International Journal of Hematology, April 2013, Springer Science + Business Media

    Dr emilio besada

  13. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in Granulomatosis with Polyangiitis: Results from a single centre

    Article • La Presse Médicale, April 2013, Elsevier

    Dr emilio besada

  14. Cyclophosphamide effect on immunoglobulins levels in AAV patients treated with long-term pre-emptive rituximab maintenance

    Article • La Presse Médicale, April 2013, Elsevier

    Dr emilio besada

  15. Infection Risks During Longterm Rituximab Therapy Change Over Time

    Article • The Journal of Rheumatology, February 2013, The Journal of Rheumatology

    Dr emilio besada

  16. Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis

    Article • Rheumatology International, August 2012, Springer Science + Business Media

    Dr emilio besada

  17. Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab

    Article • Clinical Rheumatology, June 2012, Springer Science + Business Media

    Dr emilio besada

  18. Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center

    Article • QJM, February 2012, Oxford University Press (OUP)

    Dr emilio besada

  19. Alternative explanations for development of late-onset neutropenia in rituximab-treated rheumatic disease patients: Comment on the article by Tesfa et al

    Article • Arthritis & Rheumatism, January 2012, Wiley

    Dr emilio besada

  20. Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones’s Locker?

    Article • Scandinavian Journal of Rheumatology, January 2012, Taylor & Francis

    Dr emilio besada

  21. Rituximab og nøytropeni

    Article • Tidsskrift for Den norske legeforening, January 2012, Norwegian Medical Association

    Dr emilio besada

  22. Nye kriterier for revmatoid artritt

    Article • Tidsskrift for Den norske legeforening, January 2012, Norwegian Medical Association

    Dr emilio besada

  23. Sustained hypogammaglobulinemia under rituximab maintenance therapy could increase the risk for serious infections: a report of two cases

    Article • Rheumatology International, December 2011, Springer Science + Business Media

    Dr emilio besada

  24. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler’s syndrome: a case report and literature review

    Article • Clinical Rheumatology, February 2010, Springer Science + Business Media

    Dr emilio besada

  25. Microsporidiosis and Transplantation: A Retrospective Study of 23 Cases

    Article • Journal of Eukaryotic Microbiology, July 2003, Wiley

    Dr emilio besada